Company Profile
Kandy Therapeutics Limited
10753028•Private Limited With Share Capital
Get Full Access
03/05/2017
9 years
4
2
72110
very low risk
Company Overview
Registration, classification & business activity
Kandy Therapeutics Limited (10753028) is a private limited with share capital incorporated on 03/05/2017 (9 years old) and registered in reading, RG26AD. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Kandy therapeutics is a clinical-stage company focused on optimising the potential of nt-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on treating multiple symptoms of the menopause. kandy therapeutics was spun out from nerre therap...
Financial Overview
£101.95M
£22.59M
£79.35M
£100.20M
£0
Key Metrics
2
Employees
4
Directors
7
Shareholders
Board of Directors
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating